ITT Guides FY23 Adj. EPS Just Below Estimates; Hikes Dividend 10% - Update

RTTNews | 645 days ago
Stocktwits
ITT Guides FY23 Adj. EPS Just Below Estimates; Hikes Dividend 10% - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, ITT Inc. (ITT) initiated its adjusted earnings and revenue growth guidance for the full-year 2023. It also increased quarterly dividend by 10 percent.

For fiscal 2023, the company now projects earnings in a range of $4.38 to $4.78 per share and adjusted earnings in a range of $4.55 to $4.95 per share on revenue growth of 7 to 9 percent, with organic revenue growth of 6 to 8 percent.

On average, 13 analysts polled by Thomson Reuters expect the company to report earnings of $4.96 per share on revenue growth of 4.9 percent to $3.13 billion for the year. Analysts' estimates typically exclude special items.

Additionally, the company announced a 10 percent higher quarterly cash dividend of $0.29 per share on the company's outstanding common stock for the first quarter, payable on April 3, 2023, to shareholders of record as of the close of business on March 9, 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Tags: ITT
Stocktwits
read more
ITT Provides Long-term Financial Targets

ITT Provides Long-term Financial Targets

Ahead of its investor conference later on Thursday, ITT Inc. (ITT) announced long-term financial targets, which comprise 5 to 7 percent revenue growth, 20 percent adjusted segment operating margin, over 10 percent adjusted earnings per share growth, and a free cash flow margin range of 11 percent to 13 percent, all based on actual results for the year-ending December 31, 2021.
RTTNews | 883 days ago
Yen Falls Against Majors

Yen Falls Against Majors

The Japanese yen weakened against other major currencies in the Asian session on Friday.
RTTNews | 5h 5min ago
European Economic News Preview: UK GDP Data Due

European Economic News Preview: UK GDP Data Due

Quarterly national accounts from the UK and final inflation from France and Italy are due on Friday, headlining a busy day for the European economic news. At 2.00 am ET, the Office for National Statistics publishes UK GDP data for the third quarter and industrial output and foreign trade figures for September. The economy is forecast to grow 0.2 percent sequentially after rising 0.5 percent in se
RTTNews | 5h 45min ago
FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the treatment of aromatic L-amino acid decarboxylase or AADC deficiency. Kebilidi is the first FDA-approved gene therapy for the deficiency. PTC shares gained around 8.5 percent in the extended trading on the Nasdaq on Thursday.
RTTNews | 6h 17min ago
Asian Markets Mostly Higher

Asian Markets Mostly Higher

Asian stock markets are trading mostly higher on Friday, despite the broadly negative cues from Wall Street overnight, as traders react to a bunch of upbeat economic data from the region, including upbeat GDP data from Japan. Regional gains remained very modest after the U.S. Fed said it would slash interest rates carefully amid inflation pressures. Asian markets ended mixed on Thursday.
RTTNews | 8h 34min ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Broker News
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2024 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.